Cepheid has updated its Xpert Carba-R test with the addition of two emerging carbapenemase genes, OXA-181 and OXA-232. The on-demand molecular test also detects and differentiates between the five most prevalent mechanisms of carbapenem resistance, namely KPC, NDM, VIM, IMP-1 and OXA-48.
Carbapenemase gene detection
The Xpert Carba-R cartridge now detects 91 resistance genes distributed among five distinct gene families in less than an hour, many of which are extremely difficult to detect using conventional laboratory procedures,” commented Dr David Persing, Cepheid's Chief Medical and Technology Officer. “Rapid detection of these organisms in surveillance swabs allows healthcare providers to make infection control decisions quickly and avoid the inconvenience and expense of placing patients in isolation rooms unnecessarily." The updated Xpert Carba-R is now available as a CE-IVD-marked product. www.cepheidinternational.com